Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar indication. "We at Zealand Pharma are acutely aware of the significant unmet medical need for newborns and children with ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent ...

After hours: November 22 at 7:43 PM EST Loading Chart for AMPH ...

including, but not limited to Primatene MIST ®, Amphadase ®, Cortrosyn ®, REXTOVY ® and BAQSIMI ® are the property of Amphastar Pharmaceuticals, Inc. Forward Looking Statements All statements ...